Glycogen storage disease

Seminars in Hematology

Volumn 39, Issue 2, 2002, Pages 103-106

  Kannourakis, George ^a  

^a UNIVERSITY OF BALLARAT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR;

AUTOSOMAL RECESSIVE INHERITANCE; BACTERICIDAL ACTIVITY; CHROMOSOME 11Q; ENZYME ACTIVITY; ENZYME DEFICIENCY; GLUCONEOGENESIS; GLYCOGEN STORAGE DISEASE; HUMAN; MICROSOME MEMBRANE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPLENECTOMY;

EID: 0036214086     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.31920     Document Type: Article

References (32)

1. Infections and bleeding complications in patients with glycogenosis 1b
2. Recurrent infection in glycogenosis type 1b: Abnormal neutrophil motility related to impaired redistribution of adhesion sites
3. The gene for glycogen-storage disease type 1b maps to chromosome 11q23
4. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms
5. Neutropenia and impaired neutrophil migration in type 1b glycogen storage disease
6. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease 1b
7. Cornstarch therapy in type I glycogen storage disease
8. Glycogen storage diseases
9. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia
10. Safety of long-term administration of granulocyte colony stimulating factor for severe chronic neutropenia
11. Myelodysplasia and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
12. Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type 1b
13. Glycogen storage disease
14. Glycogen storage diseases
15. Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease type 1b
16. Long term follow-up on patients with glycogen storage disease 1b and severe chronic neutropenia treated with G-CSF
17. Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b
18. Impairment of calcium mobilization in phagocytic cells in glycogen storage disease type 1b
19. Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type 1b
20. Orthotopic liver transplantation for glycogen storage disease type 1b - Treatment with recombinant human granulocyte colony-stimulating factor
21. Type 1b glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system
22. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro
23. Hematologic effects of recombinant granulocyte colony-stimulating factor in patients with malignancy
24. 2+ mobilization
25. A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system
26. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma
27. Effects of recombinant human granulocyte and macrophage colony-stimulating factor on signal transduction pathways in human granulocytes
28. Ex vivo neutrophil function in response to three different doses of glycosylated rHuG-CSF (Lenograstim)
29. Impaired monocyte function in glycogen storage disease type 1b
30. Granulocyte colony stimulating factor corrects the neutropenia associated with glycogen storage disease type 1b
31. 2-generating system during differentiation of HL60 cells to neutrophil-like cells
32. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence